Kumar Ramesh 4
4 · Ocugen, Inc. · Filed Apr 20, 2022
Insider Transaction Report
Form 4
Ocugen, Inc.OCGN
Kumar Ramesh
Director
Transactions
- Sale
Common Stock
2022-04-18$2.83/sh−7,500$21,225→ 0 total - Exercise/Conversion
Option (Right to Buy)
2022-04-18+7,500→ 16,500 totalExercise: $0.51Exp: 2030-01-02→ Common Stock (7,500 underlying) - Exercise/Conversion
Common Stock
2022-04-18$0.51/sh+7,500$3,825→ 7,500 total
Footnotes (3)
- [F1]This sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.79 to $2.89. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]The options, initially representing a right to purchase 54,000 shares, vest and become exercisable in equal monthly installments over three years commencing on February 2, 2020, subject to continued service with the Company on the applicable vesting dates.